-
Mashup Score: 0
Home > Skin Cancer > Nonmelanoma Skin Cancer Is Killing More People Globally Than Melanoma Nonmelanoma skin cancer (NMSC) is responsible for more deaths worldwide than melanoma, the more serious form of skin cancer, according to a new study presented at the European Academy of Dermatology and Venereology Congress 2023. NMSC refers to a group of cancers that slowly develop in the upper layers of the skin, including basal cell carcinoma and squamous cell carcinoma. It is less likely to spread to other parts
Source: docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Non-Melanoma Skin Cancer Deaths Exceed Melanoma Deaths Globally - 7 month(s) ago
Non-melanoma skin cancer is causing more deaths than melanoma worldwide, data suggest.
Source: www.cancertherapyadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Non-melanoma #skincancer is causing more deaths than #melanoma worldwide. Presented at the @eadv #EADVcongress. https://t.co/YoxvRxYd6y #NMSC
-
-
Mashup Score: 0What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care - 7 month(s) ago
Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer (NMSC)?
Source: www.medscape.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📝 Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer? #NMSC #MedEd #OncX 🖥️ https://t.co/DwpCtaJreM https://t.co/NlfcIXFCYb
-
-
Mashup Score: 0What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care - 7 month(s) ago
Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer (NMSC)?
Source: www.medscape.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📝 Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer? #NMSC #MedEd #OncX 🖥️ https://t.co/rPWGE312BE https://t.co/gm9QdQuerI
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - ASTRO 2022: Use of HDR Brachytherapy for Non-Melanoma Skin Cancers of the Face - 1 year(s) ago
By: Joshua Swore, PhD Posted: Tuesday, November 15, 2022 High–dose rate (HDR) brachytherapy custom thermoplastic applicators may prove to be a safe and effective means of treating patients with non-melanoma skin cancers located on the face, according to a study presented at the 2022 American Society for Radiation…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASTRO22: Use of HDR Brachytherapy for #NonMelanomaSkinCancer of the Face: https://t.co/GmNKfTQVZF #JNCCN360 #NMSC #oncorad #radonc #skcsm https://t.co/HeIOEF2RjE
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - ASTRO 2022: Use of Diffusing Alpha-Emitter Radiation Therapy for Cutaneous Cancers - 1 year(s) ago
By: Vanessa A. Carter, BS Posted: Monday, November 7, 2022 During the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting (Abstract 257), Christopher A. Barker, MD, of Memorial Sloan Kettering Cancer Center, New York, and colleagues presented preliminary efficacy and safety results from a multicenter,…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASTRO22: Use of Diffusing Alpha-Emitter Radiation Therapy for Cutaneous Cancers: https://t.co/9fkHao4bQf #JNCCN360 #NMSC #radonc #oncrad #skcsm https://t.co/3nPgTrO6F2
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - Use of Vismodegib in Advanced Basal Cell Carcinoma: Findings From a Multicenter Cohort Study - 2 year(s) ago
By: Jenna Carter, PhD Posted: Tuesday, October 25, 2022 Treatment of locally advanced or inoperable metastatic basal cell carcinoma currently centers on Hedgehog inhibitors (vismodegib or sonidegib). A recent article published in the Journal of the European Academy of Dermatology and Venereology presented findings from…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Use of Vismodegib in Advanced #BasalCellCarcinoma: Findings From a Multicenter Cohort Study: https://t.co/m2a7kz6DSy #JNCCN360 #NMSC #skcsm https://t.co/vGwyDrsoHe
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - Use of Vismodegib in Advanced Basal Cell Carcinoma: Findings From a Multicenter Cohort Study - 2 year(s) ago
By: Jenna Carter, PhD Posted: Tuesday, October 25, 2022 Treatment of locally advanced or inoperable metastatic basal cell carcinoma currently centers on Hedgehog inhibitors (vismodegib or sonidegib). A recent article published in the Journal of the European Academy of Dermatology and Venereology presented findings from…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Use of Vismodegib in Advanced #BasalCellCarcinoma: Findings From a Multicenter Cohort Study: https://t.co/m2a7kz6DSy #NMSC #skcsm #JNCCN360 https://t.co/Yc7cKBRyXa
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - Adjuvant Nivolumab in Resected Merkel Cell Carcinoma: Interim Results From Phase II Trial - 2 year(s) ago
By: Julia Fiederlein Posted: Thursday, October 13, 2022 Jürgen C. Becker, MD, PhD, of the University of Duisburg-Essen, Germany, and colleagues conducted a study to investigate the safety and efficacy of adjuvant PD-1 blockade by immune checkpoint inhibition with nivolumab versus observation in patients with completely…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Adjuvant Nivolumab in Resected #MerkelCellCarcinoma: Interim Results From Phase II Trial: https://t.co/t3j65rVjup #NMSC #SKCSM #JNCCN360 https://t.co/7XqKq7qEgn
-
-
Mashup Score: 0JNCCN 360 - Non-Melanoma Skin Cancers - Adjuvant Nivolumab in Resected Merkel Cell Carcinoma: Interim Results From Phase II Trial - 2 year(s) ago
By: Julia Fiederlein Posted: Thursday, October 13, 2022 Jürgen C. Becker, MD, PhD, of the University of Duisburg-Essen, Germany, and colleagues conducted a study to investigate the safety and efficacy of adjuvant PD-1 blockade by immune checkpoint inhibition with nivolumab versus observation in patients with completely…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Adjuvant Nivolumab in Resected Merkel Cell Carcinoma: Interim Results From Phase II Trial: https://t.co/t3j65rVjup #JNCCN360 #NMSC #skcsm https://t.co/DGebtaFcDZ
-
Nonmelanoma skin cancer is responsible for more deaths worldwide than melanoma, the more serious form of skin cancer. #skincancer #melanoma #NMSC https://t.co/0kO3WNd9Fn https://t.co/z42fjfawJg